Image

Biosimilars Latam 2018 Forum

Biosimilars Latam 2018 Forum

Image
Image
Image

Summary

The regulation of similar biotherapeutic products varies widely among the different Latin American countries. While some of them are yet to introduce their own regulation, others — like Colombia, Brazil and Mexico — have opened ways to cheaper, complex and safe biological treatment for patients. However, many things need improving and a lot of experience is still necessary to develop a mature LATAM Biosimilars Market.

Biosimilars Latam - Colombia 2020 Forum is a unique and effective meeting point to share the information and experience Latin America’s Pharmaceutical Industry needs to develop a dynamic and thriving biosimilars market.

Join us in Colombia and trigger a quantum leap in Latin American Healthcare!

Who will
you meet?

More than:

 

0
Participants
0
Companies



HCPs

Patients

Academy

Investors

Institutions

Associations

Service Providers

Governmental Agencies

Industry Executives from Latam



From these areas:
  • Biosimilars
  • Biobetters
  • Biotechnology
  • Biotherapeutics
  • Analytical science
  • Regulatory compliance
  • Quality Control
  • Clinical immunology
  • Scientific Affairs
  • Pharmacovigilance
  • Research
  • Regulatory
  • Business Development
  • Marketing

Speakers

Federico Odreman

Federico Odreman

ICESI University, Colombia. Dean of the Natural Science Faculty Read More
Claudia Vaca

Claudia Vaca

Think Tank “Medicines, Information and Power” UNAL, Colombia. Founder and Head Read More
Eduardo Cioppi

Eduardo Cioppi

mAbxience, Argentina. Regional Director - Latin America Read More
Claudia Marcela Betancour

Claudia Marcela Betancour

Biointropic, Colombia. Executive Director Read More
Jose Josan

Jose Josan

Universidad Peruana Cayetano Heredia, Peru. Professor Read More
  • 1
  • 2
  • 3

Programme at a Glance

Latam Biosimilars’s Insight. Panel Industry Leaders

Edgar Mauricio Rubio
Indukern, Colombia
Pharmaceutical & Animal Health Division Manager

Eduardo Cioppi
mAbxience, Argentina
Regional Director - Latin America

Jaime Uribe
PROBIOMED, Mexico
CEO

Perception on Biosimilars from Local Patients and HCPs. Panel
Pharmacovigilance in Latam
Current Technology used in Latam for Biosimilars Development. Panel
International Standard for the Evaluation and Approval of Biologics/Biosimilars. Panel
What the Future of Biosimilars in Colombia is? Panel
Full programme in the PDF Agenda

How to attend?

Keep me updated



About "JackLeckerman"

JackLeckerman Company has been established as a business intelligence event services and the promotion of global summits, strategic conferences, open forums and professional training.

©2020 JackLeckerman. All Rights Reserved. Designed By

Search